265 related articles for article (PubMed ID: 26011400)
1. Modeling correction of severe urea cycle defects in the growing murine liver using a hybrid recombinant adeno-associated virus/piggyBac transposase gene delivery system.
Cunningham SC; Siew SM; Hallwirth CV; Bolitho C; Sasaki N; Garg G; Michael IP; Hetherington NA; Carpenter K; de Alencastro G; Nagy A; Alexander IE
Hepatology; 2015 Aug; 62(2):417-28. PubMed ID: 26011400
[TBL] [Abstract][Full Text] [Related]
2. AAV-encoded OTC activity persisting to adulthood following delivery to newborn spf(ash) mice is insufficient to prevent shRNA-induced hyperammonaemia.
Cunningham SC; Kok CY; Spinoulas A; Carpenter KH; Alexander IE
Gene Ther; 2013 Dec; 20(12):1184-7. PubMed ID: 24108150
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Cholestatic Liver Disease and Reduced Tumorigenicity in a Murine Model of PFIC Type 3 Using Hybrid AAV-piggyBac Gene Therapy.
Siew SM; Cunningham SC; Zhu E; Tay SS; Venuti E; Bolitho C; Alexander IE
Hepatology; 2019 Dec; 70(6):2047-2061. PubMed ID: 31099022
[TBL] [Abstract][Full Text] [Related]
4. Induction and prevention of severe hyperammonemia in the spfash mouse model of ornithine transcarbamylase deficiency using shRNA and rAAV-mediated gene delivery.
Cunningham SC; Kok CY; Dane AP; Carpenter K; Kizana E; Kuchel PW; Alexander IE
Mol Ther; 2011 May; 19(5):854-9. PubMed ID: 21386824
[TBL] [Abstract][Full Text] [Related]
5. Correction of ornithine transcarbamylase deficiency in adult spf(ash) mice and in OTC-deficient human hepatocytes with recombinant adenoviruses bearing the CAG promoter.
Kiwaki K; Kanegae Y; Saito I; Komaki S; Nakamura K; Miyazaki JI; Endo F; Matsuda I
Hum Gene Ther; 1996 May; 7(7):821-30. PubMed ID: 8860834
[TBL] [Abstract][Full Text] [Related]
6. Hybrid nonviral/viral vector systems for improved piggyBac DNA transposon in vivo delivery.
Cooney AL; Singh BK; Sinn PL
Mol Ther; 2015 Apr; 23(4):667-74. PubMed ID: 25557623
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus-mediated rescue of neonatal lethality in argininosuccinate synthetase-deficient mice.
Kok CY; Cunningham SC; Carpenter KH; Dane AP; Siew SM; Logan GJ; Kuchel PW; Alexander IE
Mol Ther; 2013 Oct; 21(10):1823-31. PubMed ID: 23817206
[TBL] [Abstract][Full Text] [Related]
8. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo.
Yant SR; Ehrhardt A; Mikkelsen JG; Meuse L; Pham T; Kay MA
Nat Biotechnol; 2002 Oct; 20(10):999-1005. PubMed ID: 12244327
[TBL] [Abstract][Full Text] [Related]
9. Gene delivery to the juvenile mouse liver using AAV2/8 vectors.
Cunningham SC; Dane AP; Spinoulas A; Logan GJ; Alexander IE
Mol Ther; 2008 Jun; 16(6):1081-8. PubMed ID: 18414478
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing.
Ulrich-Vinther M
Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340
[TBL] [Abstract][Full Text] [Related]
11. AAV2/8-mediated correction of OTC deficiency is robust in adult but not neonatal Spf(ash) mice.
Cunningham SC; Spinoulas A; Carpenter KH; Wilcken B; Kuchel PW; Alexander IE
Mol Ther; 2009 Aug; 17(8):1340-6. PubMed ID: 19384294
[TBL] [Abstract][Full Text] [Related]
12. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
13. Development of adenovirus hybrid vectors for Sleeping Beauty transposition in large mammals.
Hausl M; Zhang W; Voigtländer R; Müther N; Rauschhuber C; Ehrhardt A
Curr Gene Ther; 2011 Oct; 11(5):363-74. PubMed ID: 21888620
[TBL] [Abstract][Full Text] [Related]
14. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
[TBL] [Abstract][Full Text] [Related]
15. Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations.
Shen WY; Lai CM; Lai YK; Zhang D; Zaknich T; Sutanto EN; Constable IJ; Rakoczy PE
J Gene Med; 2003 Jul; 5(7):576-87. PubMed ID: 12825197
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression.
Clark KR; Sferra TJ; Lo W; Qu G; Chen R; Johnson PR
J Drug Target; 1999 Dec; 7(4):269-83. PubMed ID: 10682906
[TBL] [Abstract][Full Text] [Related]
17. Development of recombinant adeno-associated virus and adenovirus cocktail system for efficient hTERTC27 polypeptide-mediated cancer gene therapy.
Gao Y; Ng SS; Chau DH; Yao H; Yang C; Man K; Huang PT; Huang C; Huang JJ; Kung HF; Lin MC
Cancer Gene Ther; 2008 Nov; 15(11):723-32. PubMed ID: 18535618
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated viral gene therapy corrects a mouse model of argininosuccinic aciduria.
Ashley SN; Nordin JML; Buza EL; Greig JA; Wilson JM
Mol Genet Metab; 2018 Nov; 125(3):241-250. PubMed ID: 30253962
[TBL] [Abstract][Full Text] [Related]
19. Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.
High KA
Trans Am Clin Climatol Assoc; 2003; 114():337-51; discussion 351-2. PubMed ID: 12813929
[TBL] [Abstract][Full Text] [Related]
20. Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesis.
Chakraborty S; Ji H; Chen J; Gersbach CA; Leong KW
Sci Rep; 2014 Dec; 4():7403. PubMed ID: 25492703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
